Oct 31, 2025 16:00
EBS - Emergent Biosolutions, Inc.
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 9.01 1.12 (12.43%) | 0.01 (0.1%) | -0.01 (-0.1%) | 0.08 (0.8%) | 0.08 (0.89%) | 1.08 (11.93%) | -0.02 (-0.17%) | 0.05 (0.55%) |
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.22
- Diluted EPS:
- -0.22
- Basic P/E:
- -46.0455
- Diluted P/E:
- -46.0455
- RSI(14) 1m:
- 79.51
- VWAP:
- 10.12
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Mar 19, 2025 20:30
Mar 12, 2025 12:00
Feb 24, 2025 18:00
Jan 16, 2025 13:00
Dec 30, 2024 22:26
Dec 09, 2024 16:30
Dec 03, 2024 23:47
Oct 25, 2024 13:00
Oct 07, 2024 15:52